Evidence map›Paper›PMID 25892682›Full record

ReviewThe American journal of pathology2015

Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.

Paul de Figueiredo, Thomas A Ficht, Allison Rice-Ficht, Carlos A Rossetti, L Garry Adams

Abstract readReview
In one paragraph

Review in The American journal of pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 254 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
254citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

254 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Review
  9. Ability ofMicroorganisms · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

194 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul de FigueiredoDepartment of Veterinary Pathobiology, Texas A&M University and Texas AgriLife Research, College Station, Texas; Norman Borlaug Center, Texas A&M University, College Station, Texas; Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, Bryan, Texas.
Thomas A FichtDepartment of Veterinary Pathobiology, Texas A&M University and Texas AgriLife Research, College Station, Texas.
Allison Rice-FichtDepartment of Molecular and Cellular Medicine, Texas A&M Health Science Center, Bryan, Texas.
Carlos A RossettiInstitute of Pathobiology, CICVyA-CNIA, National Institute of Animal Agriculture Technology (INTA), Buenos Aires, Argentina.
L Garry AdamsDepartment of Veterinary Pathobiology, Texas A&M University and Texas AgriLife Research, College Station, Texas. Electronic address: gadams@cvm.tamu.edu.

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Improved Live Attenuated Brucella Vaccines to Reduce Human DiseasesR01HD084339 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI FICHT, THOMAS A · 2015 to 2017
$1.8M
NIAID NIH HHS 1U54 AI057156-01NIAID NIH HHS U54 AI057156NICHD NIH HHS R01 HD084339
6 · The paper itself

Abstract

This review of Brucella-host interactions and immunobiology discusses recent discoveries as the basis for pathogenesis-informed rationales to prevent or treat brucellosis. Brucella spp., as animal pathogens, cause human brucellosis, a zoonosis that results in worldwide economic losses, human morbidity, and poverty. Although Brucella spp. infect humans as an incidental host, 500,000 new human infections occur annually, and no patient-friendly treatments or approved human vaccines are reported. Brucellae display strong tissue tropism for lymphoreticular and reproductive systems with an intracellular lifestyle that limits exposure to innate and adaptive immune responses, sequesters the organism from the effects of antibiotics, and drives clinical disease manifestations and pathology. Stealthy brucellae exploit strategies to establish infection, including i) evasion of intracellular destruction by restricting fusion of type IV secretion system-dependent Brucella-containing vacuoles with lysosomal compartments, ii) inhibition of apoptosis of infected mononuclear cells, and iii) prevention of dendritic cell maturation, antigen presentation, and activation of naive T cells, pathogenesis lessons that may be informative for other intracellular pathogens. Data sets of next-generation sequences of Brucella and host time-series global expression fused with proteomics and metabolomics data from in vitro and in vivo experiments now inform interactive cellular pathways and gene regulatory networks enabling full-scale systems biology analysis. The newly identified effector proteins of Brucella may represent targets for improved, safer brucellosis vaccines and therapeutics.

Indexed as

Host-Pathogen InteractionsAnimalsBrucellaBrucellosisHumans

Identifiers

PMID25892682
PMCPMC4450313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.